Cargando…
Quality of T-cell responses versus reduction in viral load: results from an exploratory phase II clinical study of Vacc-4x, a therapeutic HIV vaccine
| Autores principales: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441273/ http://dx.doi.org/10.1186/1742-4690-9-S2-O66 |
| _version_ | 1782243252332658688 |
|---|---|
| author | Ellefsen-Lavoie, K Rockstroh, J Pollard, R Pantaleo, G Podzamczer, D Asmuth, D van Lunzen, J Arastéh, K Schürmann, D Peters, B Clotet, B Hardy, D Lazzarin, A Gatell, J Sommerfelt, MA Baksaas, I Wendel-Hansen, V Sørensen, B |
| author_facet | Ellefsen-Lavoie, K Rockstroh, J Pollard, R Pantaleo, G Podzamczer, D Asmuth, D van Lunzen, J Arastéh, K Schürmann, D Peters, B Clotet, B Hardy, D Lazzarin, A Gatell, J Sommerfelt, MA Baksaas, I Wendel-Hansen, V Sørensen, B |
| author_sort | Ellefsen-Lavoie, K |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3441273 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2012 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-34412732012-09-18 Quality of T-cell responses versus reduction in viral load: results from an exploratory phase II clinical study of Vacc-4x, a therapeutic HIV vaccine Ellefsen-Lavoie, K Rockstroh, J Pollard, R Pantaleo, G Podzamczer, D Asmuth, D van Lunzen, J Arastéh, K Schürmann, D Peters, B Clotet, B Hardy, D Lazzarin, A Gatell, J Sommerfelt, MA Baksaas, I Wendel-Hansen, V Sørensen, B Retrovirology Oral Presentation BioMed Central 2012-09-13 /pmc/articles/PMC3441273/ http://dx.doi.org/10.1186/1742-4690-9-S2-O66 Text en Copyright ©2012 Ellefsen-Lavoie et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Oral Presentation Ellefsen-Lavoie, K Rockstroh, J Pollard, R Pantaleo, G Podzamczer, D Asmuth, D van Lunzen, J Arastéh, K Schürmann, D Peters, B Clotet, B Hardy, D Lazzarin, A Gatell, J Sommerfelt, MA Baksaas, I Wendel-Hansen, V Sørensen, B Quality of T-cell responses versus reduction in viral load: results from an exploratory phase II clinical study of Vacc-4x, a therapeutic HIV vaccine |
| title | Quality of T-cell responses versus reduction in viral load: results from an exploratory phase II clinical study of Vacc-4x, a therapeutic HIV vaccine |
| title_full | Quality of T-cell responses versus reduction in viral load: results from an exploratory phase II clinical study of Vacc-4x, a therapeutic HIV vaccine |
| title_fullStr | Quality of T-cell responses versus reduction in viral load: results from an exploratory phase II clinical study of Vacc-4x, a therapeutic HIV vaccine |
| title_full_unstemmed | Quality of T-cell responses versus reduction in viral load: results from an exploratory phase II clinical study of Vacc-4x, a therapeutic HIV vaccine |
| title_short | Quality of T-cell responses versus reduction in viral load: results from an exploratory phase II clinical study of Vacc-4x, a therapeutic HIV vaccine |
| title_sort | quality of t-cell responses versus reduction in viral load: results from an exploratory phase ii clinical study of vacc-4x, a therapeutic hiv vaccine |
| topic | Oral Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441273/ http://dx.doi.org/10.1186/1742-4690-9-S2-O66 |
| work_keys_str_mv | AT ellefsenlavoiek qualityoftcellresponsesversusreductioninviralloadresultsfromanexploratoryphaseiiclinicalstudyofvacc4xatherapeutichivvaccine AT rockstrohj qualityoftcellresponsesversusreductioninviralloadresultsfromanexploratoryphaseiiclinicalstudyofvacc4xatherapeutichivvaccine AT pollardr qualityoftcellresponsesversusreductioninviralloadresultsfromanexploratoryphaseiiclinicalstudyofvacc4xatherapeutichivvaccine AT pantaleog qualityoftcellresponsesversusreductioninviralloadresultsfromanexploratoryphaseiiclinicalstudyofvacc4xatherapeutichivvaccine AT podzamczerd qualityoftcellresponsesversusreductioninviralloadresultsfromanexploratoryphaseiiclinicalstudyofvacc4xatherapeutichivvaccine AT asmuthd qualityoftcellresponsesversusreductioninviralloadresultsfromanexploratoryphaseiiclinicalstudyofvacc4xatherapeutichivvaccine AT vanlunzenj qualityoftcellresponsesversusreductioninviralloadresultsfromanexploratoryphaseiiclinicalstudyofvacc4xatherapeutichivvaccine AT arastehk qualityoftcellresponsesversusreductioninviralloadresultsfromanexploratoryphaseiiclinicalstudyofvacc4xatherapeutichivvaccine AT schurmannd qualityoftcellresponsesversusreductioninviralloadresultsfromanexploratoryphaseiiclinicalstudyofvacc4xatherapeutichivvaccine AT petersb qualityoftcellresponsesversusreductioninviralloadresultsfromanexploratoryphaseiiclinicalstudyofvacc4xatherapeutichivvaccine AT clotetb qualityoftcellresponsesversusreductioninviralloadresultsfromanexploratoryphaseiiclinicalstudyofvacc4xatherapeutichivvaccine AT hardyd qualityoftcellresponsesversusreductioninviralloadresultsfromanexploratoryphaseiiclinicalstudyofvacc4xatherapeutichivvaccine AT lazzarina qualityoftcellresponsesversusreductioninviralloadresultsfromanexploratoryphaseiiclinicalstudyofvacc4xatherapeutichivvaccine AT gatellj qualityoftcellresponsesversusreductioninviralloadresultsfromanexploratoryphaseiiclinicalstudyofvacc4xatherapeutichivvaccine AT sommerfeltma qualityoftcellresponsesversusreductioninviralloadresultsfromanexploratoryphaseiiclinicalstudyofvacc4xatherapeutichivvaccine AT baksaasi qualityoftcellresponsesversusreductioninviralloadresultsfromanexploratoryphaseiiclinicalstudyofvacc4xatherapeutichivvaccine AT wendelhansenv qualityoftcellresponsesversusreductioninviralloadresultsfromanexploratoryphaseiiclinicalstudyofvacc4xatherapeutichivvaccine AT sørensenb qualityoftcellresponsesversusreductioninviralloadresultsfromanexploratoryphaseiiclinicalstudyofvacc4xatherapeutichivvaccine |